...
首页> 外文期刊>Journal of drug delivery science and technology >Improved oral bioavailability and target delivery of 6-shogaol via vitamin E TPGS-modified liposomes: Preparation, in-vitro and in-vivo characterizations
【24h】

Improved oral bioavailability and target delivery of 6-shogaol via vitamin E TPGS-modified liposomes: Preparation, in-vitro and in-vivo characterizations

机译:通过维生素E TPGS改性脂质体改善口服生物利用度和靶向6-鞋面的递送:制备,体外和体内特征

获取原文
获取原文并翻译 | 示例

摘要

6-Shogaol is one component of ginger, which has been described to possess various health-promoting effects including anticancer, antiinflammatory, antioxidant and antiatherogenic. However, poor water solubility has limited the aforementioned health benefits and clinical applications of the drug. Herein, the aforementioned drawback was circumvented by the preparation of 6-shogaol-loaded liposome through thin-film dispersion method with TPGS as the carrier, in comparison with 6-shogaol liposome and free 6-shogaol. Appropriate indices were used for the characterization of the developed liposomes viz., particle size (PS), zeta potential (Z-potential), polydispersity index (PDI), entrapment efficiency (EE) and loading capacity (LC) while their morphologies were observed under the transmission electron microscopy (TEM).In-vitrodissolution investigation showed a substantial improvement in the accumulative release rates of liposomes comparable to the free 6-shogaol. The TPGS-modified 6-shogaol and 6-shogaol liposomes had oral relative bioavailability (RBA) of 580.04% and 281.55%, respectively, with improved t1/2, MRT, Cmax, AUC0-tand Tmax. Pertinently, the TPGS coated 6-shogaol liposome may enhance the targeting of the drug to the brain. Therefore, the TPGS coated 6-shogaol liposome could potentially improve oral bioavailability of lipophilic drugin-vivo. More importantly, the results of tissue distribution investigation suggest that TPGS coated 6-shogaol liposome may act as promising carrier for brain delivery in future.
机译:6-Shogaol是生姜的一种成分,生姜具有多种促进健康的作用,包括抗癌、抗炎、抗氧化和抗动脉粥样硬化。然而,水溶性差限制了该药物的上述健康益处和临床应用。在此,与6-舒高尔脂质体和游离6-舒高尔相比,通过薄膜分散法以TPGS为载体制备6-舒高尔脂质体克服了上述缺点。所开发脂质体的表征采用了适当的指标,即:。,在透射电镜(TEM)下观察了颗粒大小(PS)、zeta电位(Z电位)、多分散指数(PDI)、包封率(EE)和负载能力(LC)及其形貌。vitrodissolution研究表明,与游离6-舒高尔相比,脂质体的累积释放率显著提高。TPGS修饰的6-shogaol和6-shogaol脂质体的口服相对生物利用度(RBA)分别为580.04%和281.55%,t1/2、MRT、Cmax、AUC0和Tmax均有改善。有针对性地,TPGS包覆的6-舒高尔脂质体可能增强药物对大脑的靶向性。因此,TPGS包被的6-shogaol脂质体有可能提高亲脂性药物在体内的口服生物利用度。更重要的是,组织分布研究结果表明,TPGS包被的6-shogaol脂质体有望成为未来脑内给药的载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号